CD276 Protein (CD276) (partial) (His tag)

Catalog No. ABIN5608362

This Recombinant CD276 protein is produced in HEK-293 Cells.

Quick Overview for CD276 Protein (CD276) (partial) (His tag) (ABIN5608362)

Target: CD276

Protein Type: Recombinant

Origin: Human

Source: HEK-293 Cells

Application: Western Blotting (WB)

Purity: >95 % as determined by SDS-PAGE.

Product Details

Protein Characteristics: partial

Purification tag / Conjugate: This CD276 protein is labelled with His tag.

Sequence: Leu 29 - Pro 245

Endotoxin Level: Endotoxin level is less than 1.0 EU per ug by the LAL method.

Application Details

Application Notes: This recombinant protein can be used for WB.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: PBS, pH 7.4

Handling Advice: Avoid repeated freeze-thaw cycles.

Storage: -20 °C,-80 °C

Storage Comment: Lyophilized Protein should be stored at -20°C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20°C or -70°C.

Target Details

Target: CD276

Alternative Name: B7-H3

Background: B7 homolog 3 (B7-H3), a member of the immunoglobulin superfamily, is also known CD276, which contains two Ig-like C2-type (immunoglobulin-like) domains and two Ig-like V-type (immunoglobulin-like) domains. B7-H3 may participate in the regulation of T-cell-mediated immune response. B7-H3 also plays a protective role in tumor cells by inhibiting natural-killer mediated cell lysis as well as a role of marker for detection of neuroblastoma cells. Furthermore, B7-H3 is involved in the development of acute and chronic transplant rejection and in the regulation of lymphocytic activity at mucosal surfaces. It could also play a key role in providing the placenta and fetus with a suitable immunological environment throughout pregnancy.

Molecular Weight: 25.2 kDa

Gene ID: 80381

Pathways: Cancer Immune Checkpoints